NCT02972606

Brief Summary

Presently, there are few options for medically managing HIV-related painful peripheral sensory neuropathy (HIV-SN). Psychological treatments, including Cognitive Behavioural Therapy (CBT), represent a potentially viable addition to the treatment of painful HIV-SN. However, there is a scarcity of research on psychological treatment approaches for pain management in people with HIV. This study will use in-depth semi-structured interviews to examine the needs of people with painful HIV-SN for a psychologically-based pain management treatment that may be delivered over the Internet. Interview questions will examine participants' needs in terms of treatment content and delivery format. Men and women, ethnic minorities, and people who use recreational drugs will be sampled to ensure that interview responses reflect the views of people most commonly suffering from this condition. Approximately 30 people will be recruited for the study. The interviews will be audio recorded, transcribed verbatim, and coded to identify themes. The interview responses will be used to develop and tailor a version of CBT for people with painful HIV-SN. It is hoped that tailoring the treatment based on the qualitative interview responses will increase the acceptability of the treatment and will improve treatment adherence rates for a future study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2016

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

November 18, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 23, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2017

Completed
5.5 years until next milestone

Results Posted

Study results publicly available

January 11, 2023

Completed
Last Updated

January 11, 2023

Status Verified

September 1, 2016

Enrollment Period

9 months

First QC Date

November 18, 2016

Results QC Date

September 15, 2021

Last Update Submit

April 13, 2022

Conditions

Keywords

HIVPeripheral NeuropathyChronic PainQualitative Research

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Completed a Semi-Structure Interview

    Semi-structured interview performed at one occasion where the patient describes his/her experience living with painful peripheral neuropathy and his/her thoughts about a psychological treatment for managing pain.

    Day 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People with HIV and painful peripheral neuropathy. We will purposively sample men, women, ethnic minorities, and people who use recreational drugs .

You may qualify if:

  • Adults aged 18 years or older.
  • Living with HIV.
  • A positive screen for peripheral sensory neuropathy, as indicated by: presence of self-reported bilateral foot pain and/or numbness in a symmetrical distribution.
  • Positive screen for symptoms of neuropathic pain in the feet, as indicated by a score of greater than or equal to 3 on the patient reported outcomes section of the Neuropathic Pain Interview.
  • Pain in the feet present most days for at least 3 months.
  • Average pain intensity of greater than or equal to 4/10.
  • Average interference of pain with daily activities is greater than or equal to 4/10.

You may not qualify if:

  • Presence of excessive alcohol consumption, hypothyroidism, vitamin B12 deficiency, diabetes, exposure to isoniazid or chemotherapy drug treatment, or a known history of a neuropathy due to a cause other than HIV or antiretroviral treatment
  • Unable to conduct interview in English.
  • Current diagnosis of dementia or learning disability.
  • Unwilling to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

King's College London

London, SE1 9RT, United Kingdom

Location

Chelsea & Westminster Hospital NHS Foundation Trust

London, SW10 9NH, United Kingdom

Location

Related Publications (1)

  • Scott W, Garcia Calderon Mendoza Del Solar M, Kemp H, McCracken LM, C de C Williams A, Rice ASC. A qualitative study of the experience and impact of neuropathic pain in people living with HIV. Pain. 2020 May;161(5):970-978. doi: 10.1097/j.pain.0000000000001783.

    PMID: 31855944BACKGROUND

Related Links

MeSH Terms

Conditions

Peripheral Nervous System DiseasesChronic Pain

Condition Hierarchy (Ancestors)

Neuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr Whitney Scott
Organization
King's College London

Study Officials

  • Whitney Scott, PhD

    King's College London

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2016

First Posted

November 23, 2016

Study Start

November 1, 2016

Primary Completion

July 31, 2017

Study Completion

July 31, 2017

Last Updated

January 11, 2023

Results First Posted

January 11, 2023

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations